4th Annual Single Cell Analysis USA Congress
23-24 October 2018, Boston, USA

Keep up to date with the latest in single cell analysis tools, technologies and applications at Oxford Global's 4th Annual Single Cell Analysis USA Congress taking place on the 23-24th October 2018 in Boston.
Building on the success of our previous events, the congress will once again be co-located with our 4th Annual Next Generation Sequencing and Clinical Diagnostics USA Congress. The congress annually attracts over 200 attendees from leading healthcare and academic institutions as well as leading pharmaceutical and biotech companies and features 3 outstanding streams:

• Single Cell 'Omics Analysis: Current and Emerging Tools
• Translation to Diagnostic and Therapeutic Applications
• Overcoming Single Cell Analysis Challenges

View the agenda 

This prestigious congress brings together over 200 key opinion leaders to discuss topic areas ranging from data analysis, single cell RNA sequencing, diagnostics and single cell technologies in drug discovery and therapeutic development. With over 30 focused single cell analysis presentations this congress allows you to harness the knowledge of a leading panel of experts in the field. Key presentations include: Single Cell Optical Analyses for Drug Discovery, Including Immunomodulatory Therapies, Andrea Pomerantz, Novartis; The Spatial Environment And Single-Cell Analysis, Guo-Cheng Yuan, Dana-Farber Cancer Institute and Transcriptomic Analysis In Immunology & Cancer Research, Virginia Savova, Sanofi.

Speakers include:

• Priyanka Vijay, Senior Scientist, Computational Genomics, AbbVie
• James Hicks, Professor (Research) of Biological Sciences, University of Southern California
• Manolis Kellis, Professor and Head, MIT Computational Biology, Massachusetts Institute of Technology
• Holger Schmidt, Professor, Electrical Engineering, University of California Santa Cruz
• Scott Tebbutt, Associate Professor & Chief Scientific Officer, University of British Columbia & PROOF Centre of Excellence
• Cheng-Zhong Zhang, Assistant Professor of Biomedical Informatics, Harvard Medical School
For further information regarding the conference programme, prices and possible discounts, please contact Angela Fernandez Saez on a.saez@oxfordglobal.co.uk or call +44 (0)1865 248 455.

4th Annual Next Generation Sequencing & Clinical Diagnostics USA Congress 

23-24 October 2018, Boston, USA

Keep up to date with the latest in next generation sequencing tools, technologies and applications at Oxford Global's 4th Annual Next Generation Sequencing and Clinical Diagnostics USA Congress taking place on the 23-24th October 2018 in Boston.
Building on the success of our previous events, this event will once again be co-located with our 4th Annual Single Cell Analysis Congress and will feature innovative insights into therapeutic applications, advances in data analysis and NGS in drug discovery, biomarker development and precision medicine. The congress features 3 outstanding streams:

• Exploring Emerging Trends in NGS Data Analysis & NGS Application Strategies
- New part-stream for 2018: Future Forward: Where Will Sequencing Take Us?
• Precision Medicine, Biomarker Development and Clinical Diagnostics
• The Applications of NGS in Different Therapeutic Areas

View the agenda.

This prestigious congress brings together over 200 key opinion leaders to discuss topic areas ranging from novel methods to NGS data analysis and whole genome sequencing allowing you to harness the knowledge of an expert panel of over 30 leading figures. Key presentations include: NGS-based clinical diagnostics for comprehensive genomics profiling and liquid biopsies in molecular pathology by Sabah Kadri; Live Analysis Of Illumina Sequence Data While The Sequencer Is Still Running by Bernhard Renard, Robert Koch Institute and Clinical And Informatic Approaches To Genomic Screening, Matthew Lebo, Director Bioinformatics and Assistant Professor Pathology, Brigham and Woman's Hospital. 

Speakers include:

• Chris Roberts, Associate Director of Computational Biology, Biogen
• Frank Slack, Director, Institute for RNA Medicine, Harvard Medical School
• Toby Bloom, Deputy Scientific Director, Informatics, New York Genome Center
• Elizabeth Azzato, Director, Molecular Pathology, St. Jude Children’s Research Hospital
• Heather Mason-Suares, Associate Director, Laboratory for Molecular Medicine
• Mike Makrigiorgos, Professor and Head, MIT Computational Biology, Dana Faber Cancer Institute
• Leonard Lipovich, Associate Professor, Center for Molecular Medicine and Genetics, Wayne State University
For further information regarding the conference programme, prices and possible discounts, please contact Angela Fernandez Saez on a.saez@oxfordglobal.co.uk or call +44 (0)1865 248 455.